Food Allergy Institute, honestly reviewed
Families report life-changing graduations. Others raise pointed questions about pricing and published evidence. Both parts of the record are real, and this page shows both.
Food Allergy Institute is one of the two leading in-person food allergy clinics in the US. Its Tolerance Induction Program has thousands of patients, publishes a 2.5-to-4-year duration at $979 a month ($1,079 for ages 26+), and families in public threads describe children who now eat freely. The public record also includes real criticism: a BBB rating of C+ with one unanswered complaint, a 2021 patient petition asking for published outcome data, and journalists quoting allergists who question the advertised 99% figure. Neither half cancels the other. Curex competes with FAI, so verify everything here against the sources and ask the clinic your own questions.
Medically reviewed by Dr. Chet Tharpe, M.D. · Last reviewed September 2026
What it is
The program, in its own terms
Food Allergy Institute and Latitude are the leading in-person food allergy clinics. They have seen thousands of patients and use their own proprietary protocols, normally a combination of sublingual immunotherapy (SLIT) and oral immunotherapy (OIT). They require frequent clinic visits and can cost $10,000+ per year of treatment.
Food Allergy Institute’s version is the Tolerance Induction Program (TIP): a proprietary protocol that starts from structurally similar proteins rather than the allergen itself, publishes a 2.5-to-4-year typical duration, treats ages 15 months to 50 years, and reports that more than half its patients travel from outside California. A New Jersey clinic opens 15 September 2026.
Curex competes in this market — we run the only fully at-home food allergy program — so read this page as a competitor’s honest summary of the public record, check every claim against the sources, and ask each provider your own questions.
The record
Both halves, with sources
Public reviews of this clinic are polarised, not average — the same shape we found in our own reviews, and it deserves the same honest treatment.
Themes from public sources — not our claims.
- BBB rating C+Not accredited; the profile notes a failure to respond to one complaint. (bbb.org, checked September 2026.)
- A 2021 transparency petitionA Change.org petition signed by 312 people asked for published safety and outcome data, disclosure of research oversight, and clarity on affiliated labs.
- Journalist-collected skepticismA 2021 Undark investigation quoted academic allergists who doubted the advertised 99% figure and noted the supporting study was a 51-patient retrospective without a control group.
- Costs beyond the subscriptionPatients publicly report lab bills their insurance rejected and an annual fee after reaching remission that they say was not upfront. Ask for the all-in figure in writing.
Also themes from public sources.
- Graduation storiesParents across many threads describe children who previously reacted to traces and now eat freely — eggs, milk, peanuts — after two to three years in the program.
- Families vote with flightsPatients travel from Florida, Texas, New York, and abroad, every 8–12 weeks, for years. Nobody sustains that for a program they consider worthless.
- 94% recommend on FacebookOf 35 public Facebook reviews. Small sample, real signal.
- A genuinely aggressive optionUnder direct in-person supervision, clinicians can push treatment faster than any remote program responsibly can. For some families that speed is exactly what they need.
The frame
Speed versus gentleness — not good versus bad
The honest trade is speed versus gentleness. Under direct supervision, clinicians can treat more aggressively — in-clinic programs normally use OIT and accelerated protocols, sometimes adding a biologic such as Xolair so the patient can safely tolerate a significant dose of allergen. The biologic protects the patient during treatment; it is the immunotherapy that modifies the disease. At-home SLIT is gentler, safer, more convenient, and more affordable. Faster is not better for every patient; neither is gentler.
That is the honest comparison frame for this clinic and for us: which program fits this patient — not which one wins. If you can reach the clinic, sustain the visits, and fund the program, aggressive in-person treatment is a legitimate choice. If you cannot, the at-home route exists precisely for you.
Before enrolling
Questions worth asking any provider — them and us
- What is the all-in annual cost in writing? Subscription, labs, food materials, visit fees, and any fees that continue after remission.
- What share of patients who start actually finish? Every published success rate has a denominator. Ask what it is.
- What happens if we pause or leave? Illness, a move, a lost job — multi-year programs meet real life. Ask about restart rules and refunds.
- What exactly does maintenance require, forever? Daily or weekly dosing after graduation is standard across immunotherapy — ours included. Know the shape of it before you start.
❓Frequently Asked Questions
The consistent theme in public threads is graduation: parents describing children who previously reacted to trace exposure and now eat the allergen freely — “my son now can eat whole egg, 4oz milk, and 16 peanuts” is a representative public comment. Facebook shows 94% of 35 reviewers recommending the clinic, and families fly in from other states and countries, which is itself a signal of perceived value.
Four verifiable things, beyond anonymous forum opinion: a Better Business Bureau rating of C+ with a notation for failure to respond to one complaint; a 2021 Change.org petition (312 signatures) asking the clinic to publish safety and outcome data, disclose research oversight, and address conflicts of interest with affiliated labs; a 2021 investigative article in Undark quoting several academic allergists who doubted the advertised success rate; and recurring patient reports of costs beyond the subscription — lab bills and an annual fee after reaching remission. Criticism of this kind is a reason to ask precise questions, not proof of wrongdoing.
It is the clinic’s own published figure, and the wording matters: 99% “after completing TIP”. The denominator is people who finished a multi-year program, not everyone who started, and completion rates are not published. The figure is self-reported rather than independently verified in a peer-reviewed journal. That does not make it false — it makes it a number whose basis you should ask about, the same standard we apply to every provider including ourselves.
Families within reach of Long Beach (or the New Jersey clinic opening September 2026) who want the most aggressive supervised approach available, can sustain frequent in-person visits over several years, and can afford a program that can exceed $10,000 a year. In-person supervision and speed are real advantages — under direct supervision clinicians can treat more aggressively than any at-home program should.
Curex is the only fully at-home food allergy program: testing through local labs or self-collection, doctors via telemedicine, and treatment shipped by the Allergychoices pharmacy. It uses sublingual immunotherapy — gentler and generally a bit slower than clinic protocols, with a much higher graduation rate because patients don’t drop out from side effects — and patients can generally save more than $10,000 over a course of treatment. Different families need different programs; neither is second-rate.
If you experience sudden difficulty breathing, throat swelling, or other signs of anaphylaxis, call 911. A prescribed epinephrine auto-injector is the first-line treatment — not antihistamines.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Keep reading
- Is Curex legit?The company, the evidence, and the concerns worth knowing — including full context on the 2025 FDA warning letter.Read
- How Curex worksThe treatment process end to end, from at-home testing to daily drops.Read
- Curex reviewsWhat patients actually report — both clusters, including the complaints.Read
- Is Curex worth the money?Plan pricing against allergy-shot costs, and who it is not worth it for.Read
- Evidence & guidelinesWhat the FDA approved, what the AAAAI/ACAAI practice parameter does and does not endorse, and what has been added since.Read
- Providers comparedCurex, Wyndly and Nectar on published prices, guarantees and evidence — including where a competitor is ahead.Read